Skip to content

Vitamin D effect on the HbA1c in diabetic patients

Effect of vitamin D on HbA1c in diabetic patients aged 7-20 years with a vitamin D deficiency

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013022811799N2
Enrollment
62
Registered
2013-08-07
Start date
2012-11-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin-dependent diabetes mellitus. Insulin-dependent diabetes mellitus.Without complications

Interventions

Vitamin D3 pearl 50/000 unit every 1 week for 10 weeks manufactured by the Farabi Pharmaceutical.
Treatment - Drugs
Vitamin D3 pearl 50/000 unit every 1 week for 10 weeks manufactured by the Farabi Pharmaceutical

Sponsors

Vice Chancellor for research , School of Medicine, Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 20 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- All patients aged 7-20 years with type I diabetes 2-Over the past 5 years have diabetes 3- HbA1c level of less than 8 at the time of the study 4-Patients' vitamin D levels measured in the same season. exclusion criteria: 1-Vitamin D supplementation in the last 6 months in patients 2- Simultaneous presence of associated diseases (hypothyroidism, celiac) 3-Obesity and weight gain in the control group 4-Lack of patient cooperation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
HbA1C. Timepoint: Before and after 2 months of intervention. Method of measurement: IU, ELIZA method.

Secondary

MeasureTime frame
Serum Calcium. Timepoint: before and 2 months after intervention. Method of measurement: mg/dl,Chyme Enzyme method.;Serum Phosphor. Timepoint: before and 2 months after intervention. Method of measurement: mg/dl, Chyme Enzyme method.;Alkalin phosphatase. Timepoint: before and 2 months after intervention. Method of measurement: U/L, Chyme Enzyme method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Alian

School of Medicine, Hamedan University of Medical Sciences

z_alian@yahoo.com+98 81 1264 0063

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026